Navigation Links
Johns Hopkins provost honored with international award
Date:5/17/2010

Lloyd Minor, M.D., an expert in balance and inner-ear disorders, and Johns Hopkins University's provost and senior vice president of academic affairs, has been awarded the Prosper Mnire Society's 2010 gold medal. The award is for Minor's contributions to understanding the scientific basis of Mnire's disease, named for the French scientist who pegged its hallmark symptoms of recurring dizziness and "constant ringing noise in the head," or so-called tinnitus, to dysfunction in the inner ear.

A medal and commemorative plaque were presented to Minor, an otolaryngologist head and neck surgeon, at a dinner ceremony in March in Austria at the Society's biannual international symposium and workshop on inner ear medicine and surgery.

Minor, who served as the Andelot Professor and director of the Department of Otolaryngology-Head and Neck Surgery at Johns Hopkins' School of Medicine from 2003 until his appointment as provost, published four key studies between 1999 and 2001, laying out the connection between head motion and eye movements and how they are controlled by the balancing mechanisms centered in the inner ear.

Most notably, colleagues say, his work advanced the diagnosis and treatment of balance disorders, including superior canal dehiscence, an often disabling form of severe dizziness. Minor perfected the condition's diagnosis and refined a surgical procedure to repair a defect in the bone in the inner ear that restored balance and hearing function in hundreds of people.

"This is a great honor for Lloyd Minor, whose dedication to patients, teaching and mentoring the next generation of physicians, and to research in the fundamental aspects of disease bear true testament to the core mission of Johns Hopkins Medicine," says Edward D. Miller, M.D., dean and CEO of Johns Hopkins Medicine. "Lloyd has proven what the famed scientist Louis Pasteur said, which was that 'chance favors the prepared mind.'"

Miller notes that during Minor's undergraduate studies, he learned how mathematics can be used to model biological pathways and expose the underlying processes, or pathology, of diseases, especially those of the nervous system. Minor later applied this knowledge to the functional anatomy of the inner ear, breaking down diseases such as Mnire's into their complex but still decipherable components. And from this, we have improved how we treat people with balance disorders, whether through balance exercises, diet, drugs or surgery.

In addition to his leading roles at Johns Hopkins, Minor is a fellow of the American College of Surgeons and American Academy of Otolaryngology Head and Neck Surgery, past president of the Association for Research in Otolaryngology and past chair of the Auditory Research Study Section of the National Institutes of Health. Minor earned both his undergraduate and medical degrees at Brown University. He completed his initial surgical residency training at Duke University, followed by a postdoctoral fellowship in vestibular physiology and residency in otolaryngology - head and neck surgery at the University of Chicago.


'/>"/>

Contact: David March
dmarch1@jhmi.edu
410-955-1534
Johns Hopkins Medical Institutions
Source:Eurekalert

Related medicine news :

1. Johns Hopkins to Unveil Center for Biotechnology Education
2. Level of frailty predicts surgical outcomes in older patients, Johns Hopkins researchers find
3. Johns Hopkins School of Medicine enters collaboration with New York Stem Cell Foundation
4. Cancer research award to Johns Hopkins basic scientist
5. Johns Hopkins Health System Acquires Imorgon Ultrasound PACS Product
6. SC Johnson and Bill & Melinda Gates Foundation Unite to Combat Malaria
7. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
8. Robert Wood Johnson Foundation Launches New Scholars, Fellows & Leadership Programs Web Site
9. Johnson & Johnson to Participate in RBC Capital Markets Health Care Conference
10. AADR awards the 2010 Jack Hein Public Service Award to David C. Johnsen
11. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: